Upregulation of Activator Protein-4 in Human Colorectal Cancer With Metastasis
Authors:
- Jie CaoJCJie Cao
- Minghua TangMTMinghua Tang
- Jintang XieJXJintang Xie
- Hong DuHDHong Du
- Hui WangHWHui Wang
- Huanqing XiaoHXHuanqing Xiao
- Yuyuan LiYLYuyuan Li
- 22 October 2008
- journal article
- Published by SAGE Publications in International Journal of Surgical Pathology
- Vol. 17 (1) , 16-21
Abstract
The aim of this study is to investigate the expression of AP-4, VEGF, and MMP-9 genes in human colorectal cancer. The expression pattern of activator protein-4 in 160 colorectal cancer compared with 32 colorectal adenomas and 32 normal colorectal tissues is demonstrated by tissue microarray-immunohistochemistry and real-time reverse transcriptase—polymerase chain reaction. Apoptosis status using terminal deoxynucleotidyl transferase—mediated dUTP nick-end labeling by comparing activator protein-4 positive versus activator protein-4 negative colorectal cancer is also assessed. The messenger RNA levels of vascular endothelial growth factor and matrix metalloproteinase-9 expression in activator protein-4 positive and negative colorectal cancer were measured using real-time reverse transcriptase— polymerase chain reaction. The activator protein-4 expression in normal colorectal tissue, adenoma, and adenocarcinoma were 4 of 32, 8 of 32, and 78 of 160, respectively. It is shown that the activator protein-4 expression was significantly correlated with the progression of colorectal cancer (P < .01) and differentiation and lymph node metastasis (P < .01). Our results also presented that the activator protein-4 expression was associated with the expression of matrix metalloproteinase-9 and vascular endothelial growth factor in the advanced colorectal cancer.Keywords
This publication has 13 references indexed in Scilit:
- S100A4 accelerates tumorigenesis and invasion of human prostate cancer through the transcriptional regulation of matrix metalloproteinase 9Proceedings of the National Academy of Sciences, 2006
- Interleukin-18-induced Human Coronary Artery Smooth Muscle Cell Migration Is Dependent on NF-κB- and AP-1-mediated Matrix Metalloproteinase-9 Expression and Is Inhibited by AtorvastatinJournal of Biological Chemistry, 2006
- Vascular endothelial growth factor receptor-1 mediates migration of human colorectal carcinoma cells by activation of Src family kinasesBritish Journal of Cancer, 2006
- Peroxisome-proliferator-activated receptor α agonists inhibit cyclo-oxygenase 2 and vascular endothelial growth factor transcriptional activation in human colorectal carcinoma cells via inhibition of activator protein-1Biochemical Journal, 2006
- Regulation of the Expression of Caspase-9 by the Transcription Factor Activator Protein-4 in Glucocorticoid-induced ApoptosisJournal of Biological Chemistry, 2005
- A promoter within the E6 ORF of human papillomavirus type 16 contributes to the expression of the E7 oncoprotein from a monocistronic mRNAJournal of General Virology, 2003
- Differential expression of DOC-1 in microsatellite-unstable human colorectal cancerOncogene, 2003
- New functions for the matrix metalloproteinases in cancer progressionNature Reviews Cancer, 2002
- Adaptor-related proteinsCurrent Opinion in Cell Biology, 2001
- Enhancer binding factors AP-4 and AP-1 act in concert to activate SV40 late transcription in vitroNature, 1988